Header image
Das Viswanath M.Sc., Ph.D.
Error message
User warning: Trying to overwrite a cache redirect for "entity_view:node:991:template_managed:[languages:language_interface]=en:[theme]=imtm:[timezone]=Europe/Prague:[user.permissions]=47340370dca61f273f6f310ffd4df7ab1bfdd3675a7f1c0dc2c39c3e3b4922bf" with one that has nothing in common, old one at address "languages:language_interface, theme, user.permissions, timezone" was pointing to "url.query_args:language", new one points to "url.query_args:language_content_entity". in Drupal\Core\Cache\VariationCache->set() (line 138 of core/lib/Drupal/Core/Cache/VariationCache.php).
About me
Viswanath Das is a Principal Investigator and Group Leader at the Institute of Molecular and Translational Medicine, Palacký University Olomouc. His research focuses on the aggregation, prion-like seeding, and propagation of disease-associated proteins, including tau, α-synuclein, and amyloid, and on developing therapeutic strategies to inhibit these processes. He leads projects supported by the Czech Science Foundation and the Czech Ministry of Health. He has published more than 40 peer-reviewed articles and supervises postdoctoral, doctoral, and master’s researchers.
Journals
Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds.
FEBS Journal.
2021,
289(7),
1929-1949,
ISSN: 1742-464X,
PMID: 34743390,
Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Experimental Neurology.
2021,
343,
113756,
ISSN: 0014-4886,
PMID: 33989658,
Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds.
Chembiochem : a European Journal of Chemical Biology.
2021,
22(18),
2741-2761,
ISSN: 1439-4227,
PMID: 33939874,
Open positions
| Project: | The role of tumor hypoxia in the emergence of acquired resistance to drugs aimed at microtubules |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Doctoral training |
| Summary: | 1 place in full-time study |
| Project: | Research and development of agents for cancer, neurodegenerative and infectious diseases |
|---|---|
| Supervisors: | De Sanctis Juan Bautista Ph.D., Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D., Urban Milan Ph.D., Das Viswanath M.Sc., Ph.D. |
| Available: | 5 |
| Intended for: | Doctoral training |
| Project: | Role of axonal transport and pathology in neurodegeneration |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 2 |
| Intended for: | Doctoral training |
| Project: | Systems approaches to understanding aging and neurodegeneration |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 2 |
| Intended for: | Doctoral training |
| Project: | Mitochondrial and microglial dysfunction in tauopathies: effects of pathogenic TAU strains |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Doctoral training |
| Summary: | 1 full-time position |
| Project: | Investigating Effects of Aggregates of Intrinsically Disordered Proteins on Microglia: Implication for Neurodegenerative Diseases |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Master training |
| Summary: | - |
| Project: | Biochemical and cellular analysis of amyloid staining agents in models of tauopathies and synucleopathies |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Master training |
| Summary: | - |
| Project: | Generation of 3D human neuronal cultures: application to modeling CNS diseases |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Master training |
| Summary: | - |
| Project: | Efficacy of Bruton Tyrosine Kinase Inhibitors Against Neuroinflammation in Neurodegenerative Diseases |
|---|---|
| Supervisors: | Das Viswanath M.Sc., Ph.D. |
| Available: | 1 |
| Intended for: | Master training |
| Summary: | - |